Group One Trading’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$162K Buy
5,100
+3,900
+325% +$106K 0.01% 4294
2025
Q4
$32.6K Sell
1,200
-3,800
-76% -$100K ﹤0.01% 5943
2025
Q3
$129K Sell
5,000
-44,000
-90% -$1.02M ﹤0.01% 5102
2025
Q2
$997K Buy
49,000
+31,000
+172% +$603K 0.03% 2769
2025
Q1
$327K Sell
18,000
-9,400
-34% -$210K 0.01% 3500
2024
Q4
$692K Sell
27,400
-78,400
-74% -$2.13M 0.02% 2905
2024
Q3
$3.6M Buy
105,800
+100,700
+1,975% +$3.84M 0.14% 1263
2024
Q2
$189K Sell
5,100
-4,000
-44% -$151K 0.01% 3439
2024
Q1
$382K Sell
9,100
-6,200
-41% -$255K 0.01% 2993
2023
Q4
$607K Sell
15,300
-1,500
-9% -$44.1K 0.02% 2910
2023
Q3
$462K Buy
16,800
+5,600
+50% +$176K 0.02% 2995
2023
Q2
$380K Sell
11,200
-28,500
-72% -$961K 0.02% 3296
2023
Q1
$1.43M Sell
39,700
-2,500
-6% -$108K 0.07% 1824
2022
Q4
$1.88M Sell
42,200
-400
-0.9% -$14.3K 0.06% 1878
2022
Q3
$1.2M Sell
42,600
-84,800
-67% -$2.6M 0.04% 2384
2022
Q2
$3.44M Buy
127,400
+89,200
+234% +$2.59M 0.1% 1583
2022
Q1
$1.3M Buy
38,200
+8,700
+29% +$278K 0.03% 2824
2021
Q4
$1.14M Sell
29,500
-1,800
-6% -$78.4K 0.02% 3221
2021
Q3
$1.69M Buy
31,300
+7,800
+33% +$366K 0.04% 2834
2021
Q2
$786K Sell
23,500
-4,700
-17% -$129K 0.02% 3678
2021
Q1
$581K Buy
28,200
+11,700
+71% +$269K 0.01% 3848
2020
Q4
$289K Sell
16,500
-53,000
-76% -$954K 0.01% 3772
2020
Q3
$1.03M Sell
69,500
-28,700
-29% -$336K 0.05% 2161
2020
Q2
$1.28M Buy
98,200
+78,700
+404% +$349K 0.08% 1811
2020
Q1
$32K Buy
19,500
+16,500
+550% +$37.3K ﹤0.01% 3984
2019
Q4
$7K Sell
3,000
-10,800
-78% -$25.1K ﹤0.01% 4678
2019
Q3
$29K Buy
13,800
+11,800
+590% +$27.3K ﹤0.01% 4218
2019
Q2
$5K Sell
2,000
-30,400
-94% -$103K ﹤0.01% 4594
2019
Q1
$159K Buy
+32,400
New +$170K 0.02% 2864
2018
Q4
Sell
-360
Closed -$2K 5008
2018
Q3
$2K Sell
360
-487
-57% -$3.41K ﹤0.01% 5009
2018
Q2
$6K Buy
847
+360
+74% +$4.81K ﹤0.01% 4761
2018
Q1
$17K Sell
487
-5,766
-92% -$223K ﹤0.01% 4143
2017
Q4
$266K Buy
6,253
+886
+17% +$38K 0.01% 2740
2017
Q3
$230K Sell
5,367
-720
-12% -$27K 0.01% 2669
2017
Q2
$226K Sell
6,087
-8,786
-59% -$389K 0.01% 2563
2017
Q1
$805K Buy
14,873
+7,753
+109% +$404K 0.06% 1492
2016
Q4
$378K Sell
7,120
-3,320
-32% -$189K 0.02% 1964
2016
Q3
$633K Buy
10,440
+3,680
+54% +$229K 0.05% 1637
2016
Q2
$445K Sell
6,760
-15,893
-70% -$1.01M 0.04% 1820
2016
Q1
$1.28M Buy
22,653
+8,640
+62% +$972K 0.14% 1007
2015
Q4
$3.3M Buy
14,013
+460
+3% +$100K 0.27% 570
2015
Q3
$2.14M Sell
13,553
-634
-4% -$179K 0.2% 740
2015
Q2
$5.37M Sell
14,187
-2,200
-13% -$874K 0.49% 300
2015
Q1
$6.85M Buy
16,387
+3,414
+26% +$1.22M 0.73% 177
2014
Q4
$3.55M Sell
12,973
-3,007
-19% -$748K 0.35% 400
2014
Q3
$3.11M Buy
15,980
+9,973
+166% +$2.17M 0.26% 473
2014
Q2
$1.47M Sell
6,007
-1,660
-22% -$375K 0.14% 889
2014
Q1
$2.03M Sell
7,667
-5,273
-41% -$2.02M 0.21% 617
2013
Q4
$4.7M Sell
12,940
-1,747
-12% -$673K 0.5% 274
2013
Q3
$7.8M Buy
14,687
+9,707
+195% +$3.33M 1.01% 108
2013
Q2
$1.17M Buy
+4,980
New +$981K 0.18% 712

Other funds holding CLDX